New third-party certification program to test for THC content in ingredients, finished products

Jennifer Grebow
Jennifer Grebow

Jennifer Grebow is the editor-in-chief of Nutritional Outlook, an award-winning media-content provider in the dietary supplement and natural products market. Nutritional Outlook, an MJH Life Sciences brand, provides insights and industry updates critical to manufacturers of dietary supplements, healthy foods, and nutritious beverages. Nutritional Outlook keeps industry abreast of current market trends, research updates, news, and regulatory developments. Nutritional Outlook goes beyond the 24-hour news cycle and provides in-depth analysis to help industry players navigate the challenges and changes in the near- and long-term. Nutritional Outlook is a brand of MJH Life Sciences, the largest privately held, independent, full-service medical media company in North America, dedicated to delivering trusted health care news across multiple channels.

U.S. contract laboratory Alkemist Labs is partnering with Canadian contract research organization Nutrasource to launch the new third-party certification program.

U.S. contract laboratory Alkemist Labs (Garden Grove, CA) is partnering with Canadian contract research organization Nutrasource to launch a new third-party certification program to test the THC content in ingredients and finished products. The new program will be called the International Cannabinoid Analysis Program (ICAP).

In a press release, the companies said: “The International Cannabinoid Analysis Program (ICAP) is a certification program for manufacturers and brands that is designed to provide consumers with freely available third-party-verified testing results in order to increase confidence and improve decision making in the cannabis products market. ICAP tests cannabis, hemp, and their extracts or derivative products with appropriate methods to ensure they contain less than 0.20% delta-9-tetrahydrocannabinol. The limit is in alignment with the European regulations, the most stringent global standards.”

Samples are already being beta-tested under the new program, and the companies expect the program to officially launch in September.

Trustworthy verifications are increasingly important as regulatory bodies like the FDA scrutinize the fast-growing hemp CBD and extract market. “Clearly, accurate testing in this product category is a concern, as evidenced by several comments at the recent FDA meeting on CBD regulation,” said Elan Sudberg, Alkemist Labs’ CEO, in the press release. “The expertise of our two companies working together brings a high level of credibility to this program.”